Not Yet RecruitingNot Applicable

Efficacy of Aligners vs ABT and RCOS for Deep Bite Correction: CBCT Study

27 participantsStarted 2025-10-01

Plain-language summary

This prospective clinical trial aims to evaluate the efficacy of clear aligner therapy compared to two different treatment modalities - anterior bite turbos and reverse curve of Spee (RCOS) archwires - for the correction of dental deep bite cases. Deep bite malocclusion is characterized by excessive vertical overlap of the anterior teeth and often requires intrusion of anterior teeth and leveling of the curve of Spee. In this study, 27 patients aged 16-30 years with an overbite ≥5 mm and no significant skeletal discrepancies will be randomly assigned into three equal groups: Group 1 (RCOS archwire), Group 2 (anterior bite turbos), and Group 3 (clear aligners). Cone-beam computed tomography (CBCT) will be used to assess changes in overbite and alveolar bone height and thickness before and after treatment. The primary outcome is the efficacy of overbite correction, and the secondary outcome is the assessment of alveolar bone remodeling. The study will be conducted at the Department of Orthodontics, Faculty of Dental Medicine, Al-Azhar University (Assiut Branch), and has been approved by the institutional ethical committee.

Who can participate

Age range

16 Years – 30 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Age between 16 and 30 years. Overbite of 5 mm or more. Full permanent dentition (excluding third molars). Good oral hygiene. No previous orthodontic or orthognathic treatment. Exclusion Criteria: * Severe skeletal Class II or III requiring surgery. Overjet greater than 6 mm. Craniofacial anomalies. Systemic diseases.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in overbite

Timeframe: Baseline and 6 months after treatment start

Trial details

NCT IDNCT07096401

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-01

View on ClinicalTrials.gov More Deep Bite Malocclusion trials